Cara Therapeutics | CARA - Attività Correnti





Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Cara Therapeutics USD 31.54M 6.9M 2025-12
Cassava Sciences USD 87.96M 9.74M 2026-03
Chugai Pharma JPY 1.54T 201.32B 2026-03
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 1B 177.83M 2026-03
J&J USD 59.17B 3.55B 2026-03
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Pacira USD 514.96M 33.01M 2026-03
Pfizer USD 42.82B 76M 2026-03
RedHill Biopharma USD 6.53M 6.03M 2025-12
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12